Posted by Michael Wonder on 01 Feb 2017
Senate inquiry on prostheses pricing urged to consider implications
31 January 2017 - AusBiotech has made a submission to the Senate’s Community Affairs References Committee Inquiry into the ‘Price regulation associated with the Prostheses List Framework’, urging the Inquiry to carefully consider the impacts of pricing reforms.
AusBiotech members are concerned at a perceived lack of recognition of the direct and indirect impacts from prostheses benefits reform on Australian innovation, research and development, manufacturing and importation in the medical technology sector.
Members support a reform process that fully considers the broader implications of modification of the Prostheses List (PL); concerned that the Australian medical technology industry will be collateral damage in pursuit of minimising cost if a well-constructed and considered reform is not achieved.
